The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Antibiotics in the clinical pipeline in 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Ranade, V. V. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31817c941f · Cited by 2,775
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Antibiotics: Actions, Origins, Resistance
Walsh, C. T. (2003) · Medical Entomology and Zoology · Cited by 675
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site
Rock, F. L., Mao, W., Yaremchuk, A., Tukalo, M., Crépin, T., Zhou, H., Zhang, Y.-K., Hernandez, V., Akama, T., Baker, S. J., et al. (2007) · Science · doi:10.1126/science.1142189 · Cited by 631
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Molecular basis of triclosan activity
Levy, C. W., Roujeinikova, A., Sedelnikova, S., Baker, P. J., Stuitje, A. R., Slabas, A. R., Rice, D. W., & Rafferty, J. B. (1999) · Nature · doi:10.1038/18803 · Cited by 518
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Protopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371
Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803899200 · Cited by 364
Natural products — The future scaffolds for novel antibiotics?
Butler, M. S., & Buss, A. D. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.012 · Cited by 337
Self-citationDihydrofolate reductase inhibitors as antibacterial agents
Hawser, S., Lociuro, S., & Islam, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.052 · Cited by 335
Baker, S. J., Zhang, Y.-K., Akama, T., Lau, A., Zhou, H., Hernandez, V., Mao, W., Alley, M. R. K., Sanders, V., & Plattner, J. J. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0603724 · Cited by 314
De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
Choi, S., Isaacs, A., Clements, D., Liu, D., Kim, H., Scott, R. W., Winkler, J. D., & DeGrado, W. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811818106 · Cited by 308
Actinonin, a Naturally Occurring Antibacterial Agent, Is a Potent Deformylase Inhibitor
Chen, D. Z., Patel, D. V., Hackbarth, C. J., Wang, W., Dreyer, G. B., Young, D. C., Margolis, P. S., Wu, C., Ni, Z.-J., Trias, J., et al. (2000) · Biochemistry · doi:10.1021/bi992245y · Cited by 298
Hamad, B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3267 · Cited by 294
Rustomjee, R., Diacon, A. H., Allen, J., Venter, A., Reddy, C., Patientia, R. F., Mthiyane, T. C. P., De Marez, T., van Heeswijk, R., Kerstens, R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-07 · Cited by 278
Chloramines as intermediates of oxidation reaction of amino acids by myeloperoxidase
Zgliczyński, J. M., Stelmaszyńska, T., Domański, J., & Ostrowski, W. (1971) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(71)90281-6 · Cited by 275
Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
Lu, H., & Tonge, P. J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700156e · Cited by 254
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Photodynamic Effects of Novel XF Porphyrin Derivatives on Prokaryotic and Eukaryotic Cells
Maisch, T., Bosl, C., Szeimies, R.-M., Lehn, N., & Abels, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1542-1552.2005 · Cited by 232
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
Discovering new antimicrobial agents
Moellering, R. C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.018 · Cited by 227
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Structural basis and mechanism of enoyl reductase inhibition by triclosan
Stewart, M. J., Parikh, S., Xiao, G., Tonge, P. J., & Kisker, C. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2907 · Cited by 225
Russell, A. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh171 · Cited by 223
Haagsma, A. C., Abdillahi-Ibrahim, R., Wagner, M. J., Krab, K., Vergauwen, K., Guillemont, J., Andries, K., Lill, H., Koul, A., & Bald, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01393-08 · Cited by 221
Nontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200352791 · Cited by 211
Challenges of antibacterial discovery revisited
Gwynn, M. N., Portnoy, A., Rittenhouse, S. F., & Payne, D. J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05828.x · Cited by 193
Nontoxic Membrane‐Active Antimicrobial Arylamide Oligomers
Liu, D., Choi, S., Chen, B., Doerksen, R. J., Clements, D. J., Winkler, J. D., Klein, M. L., & DeGrado, W. F. (2004) · Angewandte Chemie · doi:10.1002/ange.200352791 · Cited by 184
Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.
COOPER, R. D. G., SNYDER, N. J., ZWEIFEL, M. J., STASZAK, M. A., WILKIE, S. C., NICAS, T. I., MULLEN, D. L., BUTLER, T. F., RODRIGUEZ, M. J., HUFF, B. E., et al. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.575 · Cited by 181
Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents
Payne, D. J., Miller, W. H., Berry, V., Brosky, J., Burgess, W. J., Chen, E., DeWolf, W. E., Fosberry, A. P., Greenwood, R., Head, M. S., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3118-3124.2002 · Cited by 170
Origin, structure, and activity in vitro and in vivo of dalbavancin
Malabarba, A., & Goldstein, B. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki005 · Cited by 167
Ward, W. H. J., Holdgate, G. A., Rowsell, S., McLean, E. G., Pauptit, R. A., Clayton, E., Nichols, W. W., Colls, J. G., Minshull, C. A., Jude, D. A., et al. (1999) · Biochemistry · doi:10.1021/bi9907779 · Cited by 161
In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa
Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., & Hatano, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00860-06 · Cited by 140
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139
N-chlorotaurine, a natural antiseptic with outstanding tolerability
Gottardi, W., & Nagl, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp466 · Cited by 136
The pleuromutilin antibiotics: a new class for human use.
Novak, R., & Shlaes, D. M. (2010) · PubMed · Cited by 135
The mechanism of action of ramoplanin and enduracidin
Fang, X., Tiyanont, K., Zhang, Y., Wanner, J., Boger, D. L., & Walker, S. (2005) · Molecular BioSystems · doi:10.1039/b515328j · Cited by 135
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
PARENTI, F., PAGANI, H., & BERETTA, G. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.247 · Cited by 128
CAVALLERI, B., PAGANI, H., Volpe, G., Selva, E., & Parenti, F. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.309 · Cited by 128
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Belley, A. C., McKay, G. A., Arhin, F. F., Sarmiento, I., Beaulieu, S., Fadhil, I., Parr, T. R., & Moeck, G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00760-10 · Cited by 120
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Stoking the antibiotic pipeline
Morel, C. M., & Mossialos, E. A. (2010) · BMJ · doi:10.1136/bmj.c2115 · Cited by 117
The emergence of ‘hypervirulence’ in Clostridium difficile
Cartman, S. T., Heap, J. T., Kuehne, S. A., Cockayne, A., & Minton, N. P. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.008 · Cited by 115
Prokocimer, P., Bien, P. A., Surber, J., Mehra, P., DeAnda, C., Bulitta, J. B., & Corey, G. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00076-10 · Cited by 115
Ma, Z., Clark, R. F., Brazzale, A., Wang, S., Rupp, M., Li, L., Griesgraber, G. W., Zhang, S., Yong, H., Phan, L., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0102349 · Cited by 112
Louie, T., Miller, M., Donskey, C. J., Mullane, K. M., & Goldstein, E. J. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01442-07 · Cited by 112
Seiradake, E., Mao, W., Hernandez, V. S., Baker, S. J., Plattner, J. J., Alley, M. R. K., & Cusack, S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.073 · Cited by 109
Triclosan-bacteria interactions: single or multiple target sites?
Escalada, M. G., Russell, A. D., Maillard, J., & Ochs, D. (2005) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2005.01790.x · Cited by 108
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Wallis, R. S., Jakubiec, W., Kumar, V., Silvia, A. M., Paige, D., Dimitrova, D., Li, X., Ladutko, L., Campbell, S. M., Friedland, G. H., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/655471 · Cited by 105
Or, Y. S., Clark, R. F., Wang, S., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990618n · Cited by 104
Coronelli, C., White, R. J., Lancini, G., & PARENTI, F. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.253 · Cited by 101
Actinonin: an Antibiotic Substance produced by an Actinomycete
Gordon, J. J., KELLY, B. K., & MILLER, G. A. (1962) · Nature · doi:10.1038/195701b0 · Cited by 99
Kurabachew, M., Lu, S., Krastel, P., Schmitt, E. K., Suresh, B. L., Goh, A., Knox, J. E., L., N., Jiřiček, J., Beer, D., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn269 · Cited by 99
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Khardori, N. M. (2011) · Yearbook of Medicine · doi:10.1016/j.ymed.2011.08.038 · Cited by 99
Theriault, R. J., Karwowski, J. P., JACKSON, M., Girolami, R. L., SUNGA, G. N., VOJTKO, C. M., & COEN, L. J. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.567 · Cited by 99
Farrell, D. J., Robbins, M. J., Rhys‐Williams, W., & Love, W. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01285-10 · Cited by 98
Ooi, N., Miller, K., Randall, C. P., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp409 · Cited by 94
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
Ooi, N., Miller, K., Hobbs, J. K., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp299 · Cited by 92
Tiacumicins, a novel complex of 18-membered macrolides. II. Isolation and structure determination.
Hochlowski, J. E., Swanson, S., RANFRANZ, L. M., Whittern, D. N., BUKO, A. M., & McAlpine, J. B. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.575 · Cited by 88
AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
Karlowsky, J. A., Kaplan, N., Hafkin, B., Hoban, D. J., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00400-09 · Cited by 88
Clostridium difficile: progress and challenges
Bartlett, J. G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05863.x · Cited by 87
Brown, S. D., & Traczewski, M. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-09 · Cited by 84
Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
Skripkin, E. A., McConnell, T., DeVito, J., Lawrence, L. E., Ippolito, J. A., Duffy, E. M., Sutcliffe, J. A., & Franceschi, F. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-07 · Cited by 76
Park, H. S., Yoon, Y. M., Jung, S. J., Kim, C. M., Kim, J. M., & Kwak, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm236 · Cited by 75
Lipiarmycin, a new antibiotic from Actinoplanes. III. Mechanism of action.
SERGIO, S., PIRALI, G., White, R. J., & PARENTI, F. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.543 · Cited by 73
The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site
Tupin, A., Gualtiéri, M., Léonetti, J., & Brodolin, K. L. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.135 · Cited by 71
Boucher, H. W. (2010) · Clinical Infectious Diseases · doi:10.1086/647937 · Cited by 69
Mechanism and Inhibition of saFabI, the Enoyl Reductase fromStaphylococcus aureus
Xu, H., Sullivan, T. J., Sekiguchi, J., Kirikae, T., Ojima, I., Stratton, C. F., Mao, W., Rock, F. L., Alley, M. R. K., Johnson, F., et al. (2008) · Biochemistry · doi:10.1021/bi800023a · Cited by 68
A New Anti-MRSA Antibiotic Complex, WAP-8294A. I. Taxonomy, Isolation and Biological Activities.
Kato, A., Nakaya, S., KOKUBO, N., Aiba, Y., Ohashi, Y., Hirata, H., Fujii, K., & Harada, K. (1998) · The Journal of Antibiotics · doi:10.7164/antibiotics.51.929 · Cited by 67
Are natural products still the best source for antibacterial discovery? The bacterial entry factor
Silver, L. L. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.5.487 · Cited by 67
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections
Hammerschlag, M. R., & Sharma, R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.387 · Cited by 62
Higgins, P. G., Stubbings, W., Wisplinghoff, H., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01637-09 · Cited by 59
Ge, Y., Whitehouse, M. J., Friedland, I. R., & Talbot, G. H. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01753-09 · Cited by 53
Lipid II and other bactoprenol-bound cell wall precursors as drug targets.
Schneider, T., & Sahl, H.-G. (2010) · PubMed · Cited by 53
What is in the pipeline for Gram-negative pathogens?
Talbot, G. H. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.1.39 · Cited by 51
Lemaire, S., Kosowska-Shick, K., Appelbaum, P. C., Verween, G., Tulkens, P. M., & Françoise Van Bambeke, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01724-09 · Cited by 51
Farrell, D. J., Robbins, M. J., Rhys‐Williams, W., & Love, W. G. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.02.008 · Cited by 47
From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Bouza, E., & Burillo, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.048 · Cited by 46
Putnam, S. D., Sader, H. S., Farrell, D. J., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.021 · Cited by 41
Lipiarmycin: An antibiotic inhibiting nucleic acid polymerases
Talpaert, M., Campagnari, F., & Clerici, L. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(75)80047-7 · Cited by 41
Krievins, D. K., Brandt, R., Hawser, S., Hadváry, P., & Islam, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01383-08 · Cited by 34
The antibacterial lead discovery challenge
(2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3289 · Cited by 34
Whither antibacterial drug discovery?
Projan, S. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.010 · Cited by 32
Recent Advances in the Inhibition of Bacterial Fatty Acid Biosynthesis
Gerusz, V. J. (2010) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(10)45018-6 · Cited by 30
KETTENRING, J. K., Ciabatti, R., Winters, G. C., et al. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.268 · Cited by 28
Structure and biological activity of lipiarmycin B.
CAVALLERI, B., Arnone, A., Modugno, E. D., Nasini, G., & Goldstein, B. P. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.308 · Cited by 27
N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines
Wang, L., Khosrovi, B., & Najafi, R. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.02.038 · Cited by 27
Gordon, J. J., Devlin, J. P., East, A. J., Ollis, W. D., Sutherland, I. O., Wright, D. E., & Ninet, L. (1975) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19750000819 · Cited by 27
Denny, W. A., & Palmer, B. D. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.207 · Cited by 25
New antibiotic agents for bloodstream infections
Vergidis, P. I., & Falagas, M. E. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.003 · Cited by 24
Waites, K. B., Reddy, N. B., Crabb, D. M., & Duffy, L. B. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2541-2542.2005 · Cited by 21
The problem of complicated skin and skin structure infections: the need for new agents
Moellering, R. C. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq250 · Cited by 17
Stieglitz rearrangement of N,N-dichloro-β,β-disubstituted taurines under mild aqueous conditions
Shiau, T. P., Houchin, A., Nair, S., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.109 · Cited by 16
Wang, J., Xiao, Y., Huang, W., Xu, N., Bai, C., Xiu, Q., Mei, C., & Zheng, Q. (2010) · Chemotherapy · doi:10.1159/000317581 · Cited by 15
Cited by
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Ribosome-targeting antibiotics and mechanisms of bacterial resistance
Wilson, D. N. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3155 · Cited by 1,054
Prospects for new antibiotics: a molecule-centered perspective
Walsh, C. T., & Wencewicz, T. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.49 · Cited by 372
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Metadata
- Authors
- Butler, M. S., & Cooper, M. A.
- Venue
- The Journal of Antibiotics
- Published
- 2011-05-18
- Volume
- 64
- Issue
- 6
- Pages
- 413-425
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2083190721
- Cited by
- 272
- References
- 112
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.